It has been reported that TAM-derived exosomes transfer miR-501-3p to tumor cells, thus targeting TGFBR3 and facilitating the development of PDAC by activating the TGF-β signaling pathway [52]. The gene discussed is TGFBR3; the disease is neoplasm.